Avid Bioservices Inc (CDMO)

[Krakonos]

CP, you may have small typo in this sentence:

Pancreatic (Bavi)

1) Also for this trial results, or at least interim results, are expected. It can be assumed that after the NSCLC debacle Peregrine will make extra efforts to verify that data, because this is not a double blinded trial and they are not cut off from the trials data. Also here the MOS expectations are very high, this trial started in JAN 2011 and finished enrolling in the beginning of 2013.


We have been waiting for possible results from Pancreatic trial to be reported before end of 2012,
so therefore enrolling must have finished sometime in 2012.
Results are now expected to be reported in 1st Q of 2013.